INTRODUCTION
Swine flu is primarily a respiratory disease caused by a reassortant virus. Though it is usually species specific (pigs), occasionally it crosses species barrier and infects humans. 4 However, secondary bacterial pneumonia may complicate viral pneumonia, especially in pediatric age group. 4 But among adults, bacterial coinfection is a rarity. 4 Here, we report a case of swine flu superinfected with carbapenem resistant klebsiella.
CASE REPORT
A 65 years old female patient presented to us with history of abrupt onset high grade fever along with chill, headache, dry cough, sore throat, myalgia, malaise and anorexia of one week duration. The patient was disoriented, dehydrated and tachypneic. . Antibiotic regimes were changed to linezolid (600 mg twice daily intravenously) and ceftazidime (2 g thrice daily intravenously). Chest x-ray PA view revealed diffuse, bilateral, interstitial and alveolar infiltrates. Steroids (hydrocortisone 100 mg twice daily on intravenous route and budesonide respules 0.5 mg/2 ml, 4 times a day through nebulisation) and bronchodilator (salbutamol respules 5 mg/2.5 ml, 4 times a day through nebulisation) were added. With these measures, vital hemodynamic parameters (pulse, respiratory rate, non-invasive blood pressure and oxygen saturation) became stable. Acute respiratory distress syndrome (ARDS) was suspected. Graveness of the situation was explained to patient party. Suction material from endotracheal tube was sent for bacteriological culture and sensitivity maintaining adequate sterility. Next day, the culture and sensitivity reports were received. The VITEK® 2 Advanced Expert System TM (AES) phenotypically identified the organism as Klebsiella spp. with ESBL (extended spectrum beta lactamase) + Carbapenemase (Metallo-or KPC i.e., Klebsiella pneumonia Carbapenemase) resistance mechanism sensitive only to colistin (minimal inhibitory concentration [MIC] <0.5 mcg/ml) and intermediate sensitivity to tigecycline (MIC 4 mcg/ml). Then, the patient was started on tigecycline (100 mg bolus followed by 50 mg every 12 hours through intravenous route). The rRT-PCR was repeated on throat swab specimen and it was negative for swine flu virus (as per report from NICED). Inspite of the treatment, the patient gradually developed hypoxia followed by type I respiratory failure. Over next two days, she developed shock and azotemia. Vasopressor was added (noradrenaline infusion started initially at 12 mcg/min and later titrated as per blood pressure). The patient experienced a rapid and progressive downhill course over the next four days by developing multi organ dysfunction syndrome. Subsequently, the patient died on the thirteenth day of admission.
DISCUSSION
Influenza occurs in seasonal epidemics affecting mainly those with extremes of ages (<6 months or >65 years) or with comorbid medical illness. About 80% of influenza deaths and most severe disease are attributable to H3N2 strains of influenza A. 5 In early months of 2009, a novel H1N1 influenza A virus descendent of the 1918 pandemic strain, appeared in Mexico.
3 It was sufficiently different from previously circulating seasonal H1N1 viruses to qualify as an antigenic shift and its resultant spread around the world has been classified as 2009 flu pandemic. This new strain of H1N1 influenza A virus is known as pandemic H1N1 or pH1N1, novel H1N1, SOIV (swine origin influenza virus) or swine flu.
Influenza epidemics due to seasonal strain used to occur as a result of minor changes in the antigenic characteristics of the hemaglutinin and neuraminidase glycoproteins of the influenza viruses (antigenic drift). 6 Morbidity and mortality associated with seasonal influenza outbreaks are significant, especially in older patients. 5 However, influenza pandemics like that of swine flu, occur less frequently due to major changes of surface glycoproteins of the viruses (antigenic shift). Groups at risk of getting affected with swine flu include those with underlying cardio-pulmonary disease, having immunosuppression, pregnancy, lactation, diabetes, obesity or neurological disabilities. 7 The clinical features of uncomplicated influenza are that of other respiratory viral infections.
Majority of the morbidity and mortality due to swine flu are attributable to pneumonia and the acute respiratory distress syndrome (ARDS). 8 Pneumonia may be primary viral or mixed viral and secondary bacterial. Those progressing to ARDS have the worst prognosis. 8 Secondary bacterial infection is much more prevalent in swine flu affected patients than their seasonal counterpart. A study on lung specimens from 77 fatal cases of pH1N1 infection found 29% prevalence of bacterial superinfection and Pneumococcus, Staphyococcus aureus, and Streptococcus pyogenes being the commonest. 4 However, Klebsiella superinfection in a swine flu patient is a rare finding. To the best of our present knowledge, it is the first case report of swine flu superinfected with carbapenem resistant Klebsiella. Carbapenemase producing bacteria are often referred to as 'superbugs' because infections caused by them are difficult to treat. Sometimes, such bacteria are sensitive to polymyxins or tigecycline 9 (in our case, it was sensitive to colistin and intermediately sensitive to tigecycline). In 2009, a Swedish national travelling India, developed UTI (urinary tract infection) caused by carbapenem resistant Klebsiella sensitive to tigecycline and colistin. After genotypic analysis of the isolate, a new strain was found which is known today as NDM-1 or New Delhi metallo-beta-lactamase-1. 10 Unfortunately in our case, genotypic analysis could not be done.
